11/14/2024
4:46 PM | 5AM Ventures IV, L.P. (Filed by)
Q32 Bio Inc. (Subject)
Q32 Bio (Subject)
| Form SC 13G/A | |
11/07/2024
6:28 AM | Q32 Bio Inc. (Filer)
Q32 Bio (Filer)
| Form 424B3 | |
11/07/2024
6:05 AM | Q32 Bio Inc. (Filer)
Q32 Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
6:16 AM | Q32 Bio Inc. (Filer)
Q32 Bio (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/25/2024
5:06 AM | Q32 Bio Inc. (Subject)
Q32 Bio (Subject)
Temasek Holdings Ltd (0001021944) (Filed by)
| Form SC 13G/A | |
10/16/2024
7:39 PM | Q32 Bio Inc. (Issuer)
Q32 Bio (Issuer)
Violette Shelia M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
5:01 AM | Manke Isaac (Reporting)
Q32 Bio Inc. (Issuer)
Q32 Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
09/27/2024
8:57 PM | Lundberg Sven Ante (Reporting)
Q32 Bio Inc. (Issuer)
Q32 Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
6:18 AM | Q32 Bio Inc. (Filer)
Q32 Bio (Filer)
| Form 424B3 | |
08/08/2024
6:04 AM | Q32 Bio Inc. (Filer)
Q32 Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:10 AM | Q32 Bio Inc. (Filer)
Q32 Bio (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/09/2024
6:15 AM | Q32 Bio Inc. (Filer)
Q32 Bio (Filer)
| Form 424B3 | |
07/09/2024
6:05 AM | Q32 Bio Inc. (Filer)
Q32 Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
4:34 PM | ARCH Venture Fund VIII, L.P. (Filed by)
Q32 Bio Inc. (Subject)
Q32 Bio (Subject)
| Form SC 13G/A | |
05/09/2024
6:26 AM | Q32 Bio Inc. (Filer)
Q32 Bio (Filer)
| Form 424B3 | |
05/09/2024
6:06 AM | Q32 Bio Inc. (Filer)
Q32 Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
6:18 AM | Q32 Bio Inc. (Filer)
Q32 Bio (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024
11:15 PM | Q32 Bio Inc. (Filer)
Q32 Bio (Filer)
| Form EFFECT | |
04/23/2024
4:00 PM | Michaud Charles Jr (Reporting)
Q32 Bio Inc. (Issuer)
Q32 Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
3:33 PM | Q32 Bio Inc. (Filer)
Q32 Bio (Filer)
| Form 10-K/A | |
04/04/2024
7:33 PM | ACORN BIOVENTURES, L.P. (Filed by)
Q32 Bio Inc. (Subject)
Q32 Bio (Subject)
| Form SC 13D | |
04/01/2024
8:52 PM | Atlas Venture Fund X, L.P. (Filed by)
Q32 Bio Inc. (Subject)
Q32 Bio (Subject)
| Form SC 13D | |
03/29/2024
3:30 PM | Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
Q32 Bio Inc. (Subject)
Q32 Bio (Subject)
| Form SC 13G | |
03/28/2024
3:28 PM | Q32 Bio Inc. (Subject)
Q32 Bio (Subject)
| Form SC 13D | |
03/27/2024
4:35 PM | LAPORTE KATHLEEN (Reporting)
Q32 Bio Inc. (Issuer)
Q32 Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:36 PM | Q32 Bio Inc. (Issuer)
Q32 Bio (Issuer)
Violette Shelia M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:36 PM | Morrison Jodie Pope (Reporting)
Q32 Bio Inc. (Issuer)
Q32 Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:37 PM | Campagna Jason (Reporting)
Q32 Bio Inc. (Issuer)
Q32 Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:39 PM | Q32 Bio Inc. (Issuer)
Q32 Bio (Issuer)
Xu Diyong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:39 PM | GRAYZEL DAVID S. (Reporting)
Q32 Bio Inc. (Issuer)
Q32 Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:40 PM | Iwicki Mark T (Reporting)
Q32 Bio Inc. (Issuer)
Q32 Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:42 PM | Manke Isaac (Reporting)
Q32 Bio Inc. (Issuer)
Q32 Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:43 PM | Q32 Bio Inc. (Issuer)
Q32 Bio (Issuer)
TZIANABOS ARTHUR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:25 PM | Lundberg Sven Ante (Reporting)
Q32 Bio Inc. (Issuer)
Q32 Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:32 PM | Q32 Bio Inc. (Issuer)
Q32 Bio (Issuer)
Violette Shelia M. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/27/2024
4:33 PM | Q32 Bio Inc. (Issuer)
Q32 Bio (Issuer)
Thistle Mary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:34 PM | Kalowski Lee (Reporting)
Q32 Bio Inc. (Issuer)
Q32 Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:14 PM | Lundberg Sven Ante (Reporting)
Q32 Bio Inc. (Issuer)
Q32 Bio (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/27/2024
4:16 PM | Atlas Venture Associates Opportunity I, L.P. (Reporting)
Atlas Venture Associates Opportunity I, LLC (Reporting)
Atlas Venture Associates Opportunity II, LLC (Reporting)
Atlas Venture Associates Opportunity II, LP (Reporting)
ATLAS VENTURE ASSOCIATES X, L.P. (Reporting)
Atlas Venture Associates X, LLC (Reporting)
Atlas Venture Fund X, L.P. (Reporting)
Atlas Venture Opportunity Fund I, L.P. (Reporting)
Atlas Venture Opportunity Fund II, L.P. (Reporting)
Q32 Bio Inc. (Issuer)
Q32 Bio (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/27/2024
4:16 PM | Iwicki Mark T (Reporting)
Q32 Bio Inc. (Issuer)
Q32 Bio (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/27/2024
4:17 PM | ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Q32 Bio Inc. (Issuer)
Q32 Bio (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
There is a little known company that is changing warfare (Ad) With geo - political instability around the world investors are flocking to defense contract stocks.
There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military. Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t |
03/27/2024
4:18 PM | Kalowski Lee (Reporting)
Q32 Bio Inc. (Issuer)
Q32 Bio (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/27/2024
4:20 PM | Campagna Jason (Reporting)
Q32 Bio Inc. (Issuer)
Q32 Bio (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/27/2024
4:21 PM | LAPORTE KATHLEEN (Reporting)
Q32 Bio Inc. (Issuer)
Q32 Bio (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/27/2024
4:22 PM | Morrison Jodie Pope (Reporting)
Q32 Bio Inc. (Issuer)
Q32 Bio (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/27/2024
4:23 PM | Q32 Bio Inc. (Issuer)
Q32 Bio (Issuer)
Xu Diyong (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/27/2024
4:24 PM | Manke Isaac (Reporting)
Q32 Bio Inc. (Issuer)
Q32 Bio (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/27/2024
4:24 PM | GRAYZEL DAVID S. (Reporting)
Q32 Bio Inc. (Issuer)
Q32 Bio (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/26/2024
8:57 PM | Q32 Bio Inc. (Filer)
Q32 Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/22/2024
9:23 AM | Homology Medicines, Inc. (Filer)
Q32 Bio (Filer)
| Form 8-K/A | |
03/15/2024
4:18 PM | Homology Medicines, Inc. (Filer)
Q32 Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2024
6:42 AM | ADAR1 Partners, LP (Filed by)
Homology Medicines, Inc. (Subject)
Q32 Bio (Subject)
| Form SCHEDULE 13G | |
03/13/2024
12:44 PM | Homology Medicines, Inc. (Filer)
Q32 Bio (Filer)
| Form POS EX | |
03/13/2024
12:36 PM | Homology Medicines, Inc. (Filer)
Q32 Bio (Filer)
| Form 424B3 | |
03/12/2024
8:56 PM | Homology Medicines, Inc. (Filer)
Q32 Bio (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/11/2024
6:32 AM | Homology Medicines, Inc. (Filer)
Q32 Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
6:37 AM | Homology Medicines, Inc. (Subject)
Q32 Bio (Subject)
| Form 425 | |
02/15/2024
3:33 PM | Homology Medicines, Inc. (Issuer)
Q32 Bio (Issuer)
TZIANABOS ARTHUR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
11:15 PM | Homology Medicines, Inc. (Filer)
Q32 Bio (Filer)
| Form EFFECT | |
02/13/2024
9:11 AM | Homology Medicines, Inc. (Filer)
Q32 Bio (Filer)
| Form S-4/A | |
02/12/2024
5:25 AM | Homology Medicines, Inc. (Filer)
Q32 Bio (Filer)
| Form S-4/A | |
01/26/2024
7:31 PM | Homology Medicines, Inc. (Filer)
Q32 Bio (Filer)
| Form S-4/A | |
01/05/2024
4:49 PM | Homology Medicines, Inc. (Issuer)
Q32 Bio (Issuer)
Michaud Charles Jr (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
4:54 PM | Alloway Paul (Reporting)
Homology Medicines, Inc. (Issuer)
Q32 Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
3:15 PM | Homology Medicines, Inc. (Issuer)
Q32 Bio (Issuer)
Michaud Charles Jr (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
3:15 PM | Alloway Paul (Reporting)
Homology Medicines, Inc. (Issuer)
Q32 Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2023
6:45 AM | Homology Medicines, Inc. (Filer)
Q32 Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/16/2023
6:46 AM | Homology Medicines, Inc. (Subject)
Q32 Bio (Subject)
| Form 425 | |
11/16/2023
6:16 AM | Homology Medicines, Inc. (Filer)
Q32 Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/16/2023
6:17 AM | Homology Medicines, Inc. (Subject)
Q32 Bio (Subject)
| Form 425 | |
